Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma
Journal
European radiology
Date Issued
2023-07-21
Abstract
To investigate the association of sarcopenia, myosteatosis, and sarcopenic obesity with survival outcomes among patients who underwent immunotherapy for advanced hepatocellular carcinoma (HCC).
Subjects
Hepatocellular carcinoma; Immunotherapy; Myosteatosis; Sarcopenia; Survival
Publisher
SPRINGER
Type
journal article
